Literature DB >> 26294353

MUC1 (CD227): a multi-tasked molecule.

Vasso Apostolopoulos1, Lily Stojanovska2, Sharron E Gargosky3.   

Abstract

Mucin 1 (MUC1 [CD227]) is a high-molecular weight (>400 kDa), type I membrane-tethered glycoprotein that is expressed on epithelial cells and extends far above the glycocalyx. MUC1 is overexpressed and aberrantly glycosylated in adenocarcinomas and in hematological malignancies. As a result, MUC1 has been a target for tumor immunotherapeutic studies in mice and in humans. MUC1 has been shown to have anti-adhesive and immunosuppressive properties, protects against infections, and is involved in the oncogenic process as well as in cell signaling. In addition, MUC1 plays a key role in the reproductive tract, in the immune system (affecting dendritic cells, monocytes, T cells, and B cells), and in chronic inflammatory diseases. Evidence for all of these roles for MUC1 is discussed herein and demonstrates that MUC1 is truly a multitasked molecule.

Entities:  

Keywords:  CD227; EMA; MUC1; MUC1 and cancer; MUC1 and disease; MUC1 and pathogens; MUC1 expression; MUC1 isoforms; MUC1 structure; PEM

Mesh:

Substances:

Year:  2015        PMID: 26294353     DOI: 10.1007/s00018-015-2014-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  238 in total

1.  Muc1 cell surface mucin attenuates epithelial inflammation in response to a common mucosal pathogen.

Authors:  Wei Guang; Hua Ding; Steven J Czinn; K Chul Kim; Thomas G Blanchard; Erik P Lillehoj
Journal:  J Biol Chem       Date:  2010-04-29       Impact factor: 5.157

2.  MUC1 upregulation by ethanol.

Authors:  M Verma; E A Davidson
Journal:  Cancer Biochem Biophys       Date:  1999-07

3.  The membrane-bound mucin Muc1 regulates T helper 17-cell responses and colitis in mice.

Authors:  Atsushi Nishida; Cindy W Lau; Mei Zhang; Akira Andoh; Hai Ning Shi; Emiko Mizoguchi; Atsushi Mizoguchi
Journal:  Gastroenterology       Date:  2011-12-24       Impact factor: 22.682

4.  Expression of mucin-1, galectin-1 and galectin-3 in human leiomyosarcoma in comparison to leiomyoma and myometrium.

Authors:  Tobias Weissenbacher; Christina Kuhn; Doris Mayr; Roman Pavlik; Klaus Friese; Christoph Scholz; Udo Jeschke; Nina Ditsch; Darius Dian
Journal:  Anticancer Res       Date:  2011-02       Impact factor: 2.480

5.  MUC1 peptide epitopes associated with five different H-2 class I molecules.

Authors:  V Apostolopoulos; J S Haurum; I F McKenzie
Journal:  Eur J Immunol       Date:  1997-10       Impact factor: 5.532

6.  Probing the conformational and dynamical effects of O-glycosylation within the immunodominant region of a MUC1 peptide tumor antigen.

Authors:  J Schuman; A P Campbell; R R Koganty; B M Longenecker
Journal:  J Pept Res       Date:  2003-03

7.  MUC1 and estrogen receptor alpha gene polymorphisms in dry eye patients.

Authors:  Yoannis Imbert; Gary N Foulks; Mark D Brennan; Marcia M Jumblatt; George John; Hassan A Shah; Catherine Newton; Farzan Pouranfar; William W Young
Journal:  Exp Eye Res       Date:  2008-06-20       Impact factor: 3.467

8.  The kinetics and temporal expression of T-cell activation-associated antigens CD15 (LeuM1), CD30 (Ki-1), EMA, and CD11c (LeuM5) by benign activated T cells.

Authors:  A Chadburn; G Inghirami; D M Knowles
Journal:  Hematol Pathol       Date:  1992

9.  The signaling pathway involved in neutrophil elastase stimulated MUC1 transcription.

Authors:  Ippei Kuwahara; Erik P Lillehoj; Takeshi Koga; Yoichiro Isohama; Takeshi Miyata; K Chul Kim
Journal:  Am J Respir Cell Mol Biol       Date:  2007-06-28       Impact factor: 6.914

10.  An evaluation of mucin-like carcinoma associated antigen (MCA) in breast cancer.

Authors:  E H Cooper; M A Forbes; A K Hancock; J J Price; D Parker
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

View more
  36 in total

1.  Comment to "Molecular approach to the classification of chronic fibrosing lung disease-there and back again".

Authors:  Giorgio Cattoretti
Journal:  Virchows Arch       Date:  2021-04-19       Impact factor: 4.064

2.  Synthesis and Immunological Evaluation of a Multicomponent Cancer Vaccine Candidate Containing a Long MUC1 Glycopeptide.

Authors:  Nitin T Supekar; Vani Lakshminarayanan; Chantelle J Capicciotti; Anju Sirohiwal; Cathy S Madsen; Margreet A Wolfert; Peter A Cohen; Sandra J Gendler; Geert-Jan Boons
Journal:  Chembiochem       Date:  2017-11-30       Impact factor: 3.164

3.  Glycosylation of MUC1 influences the binding of a therapeutic antibody by altering the conformational equilibrium of the antigen.

Authors:  Mohammadreza Movahedin; Teresa M Brooks; Nitin T Supekar; Naveen Gokanapudi; Geert-Jan Boons; Cory L Brooks
Journal:  Glycobiology       Date:  2017-07-01       Impact factor: 4.313

4.  PNA-Modified Liposomes Improve the Delivery Efficacy of CAPIRI for the Synergistic Treatment of Colorectal Cancer.

Authors:  Wenbin Diao; Ben Yang; Sipeng Sun; Anping Wang; Rongguan Kou; Qianyun Ge; Mengqi Shi; Bo Lian; Tongyi Sun; Jingliang Wu; Jingkun Bai; Meihua Qu; Yubing Wang; Wenjing Yu; Zhiqin Gao
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

5.  Biallelic Expression of Mucin-1 in Autosomal Dominant Tubulointerstitial Kidney Disease: Implications for Nongenetic Disease Recognition.

Authors:  Karl X Knaup; Thomas Hackenbeck; Bernt Popp; Johanna Stoeckert; Andrea Wenzel; Maike Büttner-Herold; Frederick Pfister; Markus Schueler; Didem Seven; Annette M May; Jan Halbritter; Hermann-Josef Gröne; André Reis; Bodo B Beck; Kerstin Amann; Arif B Ekici; Michael S Wiesener
Journal:  J Am Soc Nephrol       Date:  2018-07-26       Impact factor: 10.121

6.  Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung Fibrosis.

Authors:  Chiara Bellocchi; Jun Ying; Ellen A Goldmuntz; Lynette Keyes-Elstein; John Varga; Monique E Hinchcliff; Marka A Lyons; Peter McSweeney; Daniel E Furst; Richard Nash; Leslie J Crofford; Beverly Welch; Jonathan G Goldin; Ashley Pinckney; Maureen D Mayes; Keith M Sullivan; Shervin Assassi
Journal:  Arthritis Rheumatol       Date:  2021-02-28       Impact factor: 10.995

Review 7.  Autosomal dominant tubulointerstitial kidney disease: more than just HNF1β.

Authors:  Anthony J Bleyer; Matthias T Wolf; Kendrah O Kidd; Martina Zivna; Stanislav Kmoch
Journal:  Pediatr Nephrol       Date:  2021-05-22       Impact factor: 3.651

8.  Activation of Immune and Defense Responses in the Intestinal Mucosa by Outer Membrane Vesicles of Commensal and Probiotic Escherichia coli Strains.

Authors:  María José Fábrega; Laura Aguilera; Rosa Giménez; Encarna Varela; María Alexandra Cañas; María Antolín; Josefa Badía; Laura Baldomà
Journal:  Front Microbiol       Date:  2016-05-11       Impact factor: 5.640

9.  Activation of AMPKα mediates additive effects of solamargine and metformin on suppressing MUC1 expression in castration-resistant prostate cancer cells.

Authors:  SongTao Xiang; QiuHong Zhang; Qing Tang; Fang Zheng; JingJing Wu; LiJun Yang; Swei Sunny Hann
Journal:  Sci Rep       Date:  2016-11-10       Impact factor: 4.379

10.  Modelling the Effect of MUC1 on Influenza Virus Infection Kinetics and Macrophage Dynamics.

Authors:  Ke Li; Pengxing Cao; James M McCaw
Journal:  Viruses       Date:  2021-05-07       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.